Dr. Chinta Sidharthan

Dr. Chinta Sidharthan

Ph.D. Evolutionary Biology

Evolutionary Biology, Phylogenetics and Biogeography

Chinta Sidharthan is a writer based in Bangalore, India. Her academic background is in evolutionary biology and genetics, and she has extensive experience in scientific research, teaching, science writing, and herpetology. Chinta holds a Ph.D. in evolutionary biology from the Indian Institute of Science and is passionate about science education, writing, animals, wildlife, and conservation. For her doctoral research, she explored the origins and diversification of blindsnakes in India, as a part of which she did extensive fieldwork in the jungles of southern India. She has received the Canadian Governor General’s bronze medal and Bangalore University gold medal for academic excellence and published her research in high-impact journals.

See more

After completing her Ph.D., Chinta continued working in the field of evolutionary biology. As a post-doctoral researcher, she is exploring the phylogenetics and biogeography of gastropods in India. She has also worked as a freelance science editor and teaching assistant. She completed her high school education and an undergraduate degree in Biology from Toronto, Canada, where she also used to work as a transcription assistant helping students with learning disabilities.

Outside of work, she is an avid reader struggling to find shelf space for her ever-growing collection of books. She enjoys cooking, collecting coffee mugs, riding and tinkering with motorcycles and mountain bikes, dabbling with paints, and making metal and clay jewelry. She is a cat mom to three little monsters —Nutmeg, Cinnamon, and Pepper — and helps rescue and foster cats and dogs. She loves the outdoors and one day hopes to live in a cabin in the mountains.

She speaks seven Indian languages — some fluently and some functionally. She also speaks Spanish and French manageably well. She backpacked across Cuba during her teenage years with her parents, doubling as their Spanish translator.

See less

Articles from Chinta

Scientists find key reason for ongoing loss of smell in long-COVID

Scientists find key reason for ongoing loss of smell in long-COVID

An estimated 19 million US adults living with long-COVID

An estimated 19 million US adults living with long-COVID

Novel mRNA-lipid nanoparticle vaccine encoding four mpox virus surface proteins generates robust immune responses against orthopoxviruses

Novel mRNA-lipid nanoparticle vaccine encoding four mpox virus surface proteins generates robust immune responses against orthopoxviruses

Hybrid immunity from mRNA vaccines and breakthrough Omicron infections induces stronger immune responses against Omicron BQ.1.1

Hybrid immunity from mRNA vaccines and breakthrough Omicron infections induces stronger immune responses against Omicron BQ.1.1

WHO releases a global strategy for infection prevention and control at the 75th World Health Assembly

WHO releases a global strategy for infection prevention and control at the 75th World Health Assembly

SARS-CoV-2 and human cold coronavirus OC43 inhibit stress granule formation through Nsp15 protein

SARS-CoV-2 and human cold coronavirus OC43 inhibit stress granule formation through Nsp15 protein

Withdrawal of COVID-19 mitigation measures resulted in a rebound in Streptococcus pneumoniae cases in Germany

Withdrawal of COVID-19 mitigation measures resulted in a rebound in Streptococcus pneumoniae cases in Germany

SARS-CoV-2 structural proteins trigger periodontal fibrosis

SARS-CoV-2 structural proteins trigger periodontal fibrosis

Seroprevalence measurements reveal a higher incidence of asymptomatic SARS-CoV-2 infections among residents of three federal German states

Seroprevalence measurements reveal a higher incidence of asymptomatic SARS-CoV-2 infections among residents of three federal German states

Study identifies four new monoclonal antibodies with broad neutralizing potencies that target conserved SARS-CoV-2 epitopes

Study identifies four new monoclonal antibodies with broad neutralizing potencies that target conserved SARS-CoV-2 epitopes

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.